Global Molecular Cytogenetics Market Research Report: Forecast (2024-2030)
Molecular Cytogenetics Market Report - By Product & Service (Kits & Reagents, [Testing Kits, Probes, Fluorescent Affinity Reagents, Others], Instruments, Consumables, Software & Se...rvices), By Technique (Comparative Genomic Hybridization, [Array-based Comparative Genomic Hybridization, Standard Comparative Genomic Hybridization], Fluorescence In-situ Hybridization, Chromogenic In-situ Hybridization, Others)), By Application (Genetic Disorders, Cancer, Personalized Medicine, Others), By End Users (Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Others), Others Read more
- Healthcare
- May 2024
- 196
- PDF, Excel, PPT
Market Definition
The molecular cytogenetics is the study & diagnosis of genetic abnormalities at the molecular level, integrating advanced techniques like FISH, CGH, and NGS. Its products include probes, reagents, instruments, and software, catering to diverse applications, such as prenatal testing, cancer diagnostics, and pharmacogenomics.
Market Insights & Analysis: Global Molecular Cytogenetics Market (2024-30):
The Global Molecular Cytogenetics Market size is estimated to grow at a CAGR of around 9.3% during the forecast period, i.e., 2024-30.
the exponential growth of genomic data is fueling demand for molecular cytogenetics. Integration of multi-omics data and the development of bioinformatics tools enable efficient data management, analysis, and interpretation, facilitating the discovery of associations between genetic alterations and disease phenotypes. This growing genomic pool is anticipated to sustain market growth in the forecast period. Cancer is a primary cause of death across the world, accounting for approximately 10 million deaths every year. For instance:
- In 2022, according to the World Health Organization, nearly 400,000 children developed cancer.
Report Coverage | Details |
---|---|
Study Period | Historical Data: 2019-22 |
Base Year: 2023 | |
Forecast Period: 2024-30 | |
CAGR (2024-2030) | 9.3% |
Regions Covered | North America: The US, Canada, Mexico |
South America: Brazil, Rest of South America | |
Europe: Germany, The UK, France, Italy, Spain, Rest of Europe | |
Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific | |
Middle East & Africa: GCC, South Africa, Rest of Middle East & Africa | |
Key Companies Profiled | Agilent Technologies, Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., DH Life Sciences, LLC, Illumina, Inc., Revvity, GeneDx, LLC, Applied Spectral Imaging, Inc., Bio-Rad Laboratories, Inc., MetaSystems Probes GmbH, Oxford Gene Technology IP Limited, Empire Genomics, Inc., SciGene Corporation, BioDot, KromaTiD Inc., among others |
Unit Denominations | USD Million/Billion |
This prevalence of cancer creates significant opportunities for the market. Furthermore, the rising incidence of uncommon infections, coupled with the increasing understanding of the human genomic pool, drives research and development activities for personalized medicines, with market players introducing novel tools to enhance patient care and outcomes.
Global Molecular Cytogenetics Market Driver:
Increasing Incidence of Cancer & Genetic Disorder to Boost the Market Growth – The global surge in cancer incidence has been a major concern. Studies over the past two decades have revealed recurrent genetic abnormalities in various human diseases, potentially fueling the proliferation of cancer cases. For instance:
- In 2022, according to the American Cancer Society's report, an estimated 1.9 million individuals were diagnosed with cancer in the United States alone.
Despite individual genetic disorders being relatively rare, they collectively account for over 15,500 recognized conditions. Highlighting this trend, the World Health Organization's 2023 data indicated that congenital malformations affected 3-4% of all births, contributing to 20-30% of infant mortality cases worldwide. The growing incidence of diseases across the globe is necessitating inhabitants to undergo diagnostic tests. As a result, healthcare facilities are increasingly opting for solutions that help in the identification of potent health threats to individuals. Hence, the demand for molecular cytogenetics is increasing within the healthcare sector, amplifying the Global Molecular Cytogenetic Market growth.
Global Molecular Cytogenetics Market Opportunity:
Expansion of Hospitals & Healthcare Facilities Poses as A Significant Opportunity in the Global Molecular Cytogenetics Market – In recent years, the incidence rates of the diseases have tremendously increased owing to which there has been higher requirement across the globe to have treatment facilities. Hence, the governing authorities & non-government organizations are providing funds to construct healthcare facilities. These healthcare facilities would enhance the quality of living of individuals and minimize the death rate caused by communicable & non-communicable diseases. Additionally, the establishment of new hospitals around the world would provide a lucrative opportunity for the market players to offer their cytogenetics solutions to these facilities. Consequently, this rising development of healthcare facilities would enhance the Global Molecular Cytogenetics Market.
Furthermore, several countries are spending hefty amounts to emerge as medical tourism hubs to gain a competitive advantage over other nations. As a result, these countries are incorporating exception & lab-proven molecular cytogenetics solutions to provide diagnostics to patients suffering from genetic disorders. Thus, the rising incorporation of these solutions within healthcare facilities would continue to amplify the Global Molecular Cytogenetics Market in forecast years as well.
Global Molecular Cytogenetics Market Challenge:
High Cost & Lack of Skilled Professionals Impede Market Growth – Molecular Cytogenetics is based upon technologically advanced tools. As a result, the prices of molecular cytogenetics are relatively higher than conventional diagnostic systems. According to the company website, the average prices of molecular diagnostics systems vary from approximately USD10,000 to USD20,000. Therefore, small nursing homes rely on conventional diagnostics methods rather than molecular cytogenetics, hampering market growth. In addition, these advanced diagnostics systems require regular maintenance to ensure the smooth functioning & delivery of adequate results. This puts an additional financial burden on the healthcare facilities. As a result, a few healthcare facilities refrain from opting for these solutions, hindering the Global Molecular Cytogenetics Market growth. Additionally, since these systems are based on the latest technologies, therefore technical expertise to operate these systems is required. This further elevates the cost associated with the purchase & maintenance of these products, owing to which, end-users often use traditional diagnostic methods rather than cytogenetics, hampering market growth.
Global Molecular Cytogenetics Market Trend:
Rapid Inclination Towards Fluorescence in Situ Hybridization (FISH) Techniques to Amplify Market Growth – Consumers across the globe are becoming more aware & conscious about their health. Therefore, the individuals are undergoing frequent diagnostics tests to ensure that they are free of any genetic disorder. However, the results of the diagnostics test carried out by conventional technologies vary, due to which the trust of individuals in conventional techniques has declined. Therefore, healthcare facilities are opting for systems based on an emerging technique, called FISH. This emerging technology helps in identifying any genetic abnormalities with the most effective results as compared to results delivered by traditional diagnostic methods. Therefore, consumers are also shifting towards diagnostic methods that use FISH techniques.
Moreover, the accurate results given by this technique help healthcare professionals to offer targeted therapies to patients which improves the patient’s health. Therefore, the inclination of consumers towards customized & tailored therapies for positive health outcomes would continue to enhance the adoption of molecular cytogenetic solutions with healthcare facilities, uplifting market growth in the forecast period as well.
Global Molecular Cytogenetics Market (2024-30): Segmentation Analysis
The Global Molecular Cytogenetics Market study by MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the regional level. In accordance to the analysis, the market has been further classified as:
Based on the Product & Service:
- Kits & Reagents
- Testing Kits
- Probes
- Fluorescent Affinity Reagents
- Others
- Instruments
- Consumables
- Software & Services
Of them all, the Consumables held a dominant market share in the Global Molecular Cytogenetics market. The younger generation across the globe is following unhealthy lifestyles. As a result, the incidence rates of diseases among the younger generation or adults are increasing. These individuals ensure to undergo tests for their own well-being, as a result, the number of diagnostics tests occurring in hospitals & independent laboratories is increasing. Consumables are a pivotal part of the diagnostics testing kits and are necessarily used by the labs to conduct a test. Therefore, there is a consistent demand for the consumables across the globe.
Additionally, the governing authorities are increasingly arranging awareness programs to educate consumers about the early detection of diseases. These health campaigns often conduct diagnostics tests within the region to ensure the well-being of the individuals. Therefore, the rising health campaigns would continue to uplift the demand for the consumables, consequently, uplifting market growth.
By End Users:
- Clinical & Research Laboratories
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Among them, Clinical & Research Laboratories hold a substantial market share in the Global Molecular Cytogenetics Market. Each & every pharmaceutical & biotechnological company has its own inbuilt clinical & research laboratories, where important and pivotal research studies are conducted. These clinical labs carry out multiple tests on a daily basis as a part of the company’s product development phase. Therefore, to identify the efficacy of the products manufactured by the company, these labs conduct diagnostics tests using molecular cytogenetics solutions. Apart from the testing of the products, these solutions are also used for identifying the chromosomal abnormalities within the individuals. Therefore, these clinical labs use these solutions to identify & develop medicine associated with genetic disorders, cancer, and prenatal abnormalities. For instance:
- In 2023, as per UC San Diego Health, molecular cytogenetics plays a central role in advancing patient care by offering genetic testing services, including comprehensive chromosomal analysis, to healthcare professionals and individuals.
Furthermore, healthcare professionals are increasingly recognizing the importance of timely diagnostics to reduce the spread of the disease. Therefore, they would continue to adopt molecular cytogenetics, enlarging market size in the forthcoming years as well.
Global Molecular Cytogenetics Market (2019-30): Regional Projection
Geographically, the Global Molecular Cytogenetics Market expands across:
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Geographically, North America dominates the Global Molecular Cytogenetics Market. The region has advanced healthcare infrastructure owing to the higher investments & funding provided by the private entities. In addition, the country has research institutions that offer treatments for diseases such as cancer & other genetic disorders. Therefore, the medical facilities in the region utilize advanced molecular diagnostics systems to ensure the identification of diseases among individuals. Additionally, there has been growing awareness among the end-users in regard to their health. Consequently, the individuals undergo frequent medical tests for the early screening of the disease. Therefore, the medical facilities in the region are incorporating these systems within their healthcare facilities, uplifting market growth.
Moreover, the genetic & chronic diseases in nations in North America are further highlighting the importance of accurate diagnostic tools like molecular cytogenetics. For instance:
- In 2023, as per the statistics from the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States annually.
Additionally, the governing bodies across the nations of North America are implementing robust regulatory frameworks to ensure safety and efficacy. Therefore, several healthcare facilities would continue to adopt these solutions to comply with these regulations, contributing to market growth within the region.
Global Molecular Cytogenetics Industry Recent Development:
- 2023: Oxford Gene Technology collaborated with Applied Spectral Imaging (ASI) to enhance OTG's cytogenetic imaging & analysis solutions in Great Britain.
- 2023: ThermoFisher Scientific & Pfizer collaborated to increase localized access to next-generation sequencing-based testing for cancer patients in global markets.
Gain a Competitive Edge with Our Global Molecular Cytogenetics Market Report
- Global Molecular Cytogenetics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
- This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
- Global Molecular Cytogenetics Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.
Frequently Asked Questions
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumptions
- Executive Summary
- Global Molecular Cytogenetics Market Start-up Ecosystem, 2019-2024
- Entrepreneurial Activity
- Year-on-Year Funding Received
- Funding Received by Top Companies
- Key Investors Active in the Market
- Series-wise Funding Received
- Seed Funding
- Angel Investing
- Venture Capitalists (VC) Funding
- Others
- Global Molecular Cytogenetics Market Trends & Insights
- Global Molecular Cytogenetics Market Dynamics
- Drivers
- Challenges
- Global Molecular Cytogenetics Market Hotspots & Opportunities
- Global Molecular Cytogenetics Market Regulations & Policies
- Global Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service
- Kits & Reagents- Market Size & Forecast 2019-2030F, USD Million
- Testing Kits- Market Size & Forecast 2019-2030F, USD Million
- Probes- Market Size & Forecast 2019-2030F, USD Million
- Fluorescent Affinity Reagents- Market Size & Forecast 2019-2030F, USD Million
- Others- Market Size & Forecast 2019-2030F, USD Million
- Instruments- Market Size & Forecast 2019-2030F, USD Million
- Consumables- Market Size & Forecast 2019-2030F, USD Million
- Software & Services- Market Size & Forecast 2019-2030F, USD Million
- Kits & Reagents- Market Size & Forecast 2019-2030F, USD Million
- By Technique
- Comparative Genomic Hybridization- Market Size & Forecast 2019-2030F, USD Million
- Array-based Comparative Genomic Hybridization- Market Size & Forecast 2019-2030F, USD Million
- Standard Comparative Genomic Hybridization- Market Size & Forecast 2019-2030F, USD Million
- Fluorescence In-situ Hybridization- Market Size & Forecast 2019-2030F, USD Million
- Chromogenic In-situ Hybridization- Market Size & Forecast 2019-2030F, USD Million
- Others- Market Size & Forecast 2019-2030F, USD Million
- Comparative Genomic Hybridization- Market Size & Forecast 2019-2030F, USD Million
- By Application
- Genetic Disorders- Market Size & Forecast 2019-2030F, USD Million
- Cancer- Market Size & Forecast 2019-2030F, USD Million
- Personalized Medicine- Market Size & Forecast 2019-2030F, USD Million
- Others- Market Size & Forecast 2019-2030F, USD Million
- By End Users
- Clinical & Research Laboratories- Market Size & Forecast 2019-2030F, USD Million
- Academic Research Institutes- Market Size & Forecast 2019-2030F, USD Million
- Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2019-2030F, USD Million
- Others- Market Size & Forecast 2019-2030F, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
- By Company
- Market Share of Top Companies
- Competition Characteristics
- By Product & Service
- Market Size & Analysis
- North America Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By Technique- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- The US
- Canada
- Mexico
- The US Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Canada Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Mexico Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- South America Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By Technique- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- Brazil
- Rest of South America
- Brazil Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Europe Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By Technique- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Germany Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- The UK Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- France Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Italy Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Spain Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- The Middle East & Africa Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By Technique- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- GCC
- South Africa
- Rest of the Middle East & Africa
- GCC Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- South Africa Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Asia-Pacific Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By Technique- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- China Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Japan Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- India Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- South Korea Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Australia Molecular Cytogenetics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Service- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Global Molecular Cytogenetics Market Key Strategic Imperatives for Growth & Success
- Competition Outlook
- Company Profiles
- Agilent Technologies, Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Abbott Laboratories
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Thermo Fisher Scientific Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- DH Life Sciences, LLC
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Illumina, Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Revvity
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- GeneDx, LLC
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Applied Spectral Imaging, Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Bio-Rad Laboratories, Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- MetaSystems Probes GmbH
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Oxford Gene Technology IP Limited
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Empire Genomics, Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- SciGene Corporation
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- BioDot
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- KromaTiD Inc.
- Business Description
- Product & Service Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Agilent Technologies, Inc.
- Company Profiles
- Disclaimer